Skip to content

High-risk prostate cancer

What it is, when to operate, surgery or radiotherapy, and what may come after surgery.

Dr. Petronio Melo, urologistA reference in prostate cancer
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 14, 2026
Book a consultation
Drawing of the prostate in cross-section, seen from above, with the rectum below and a tumor that grows through the capsule on one side and reaches the erection nerves
On this page

Quick answer

High-risk prostate cancer has ISUP grade group 4 or 5 on biopsy or a PSA above 20 ng/mL. When the tumor has grown beyond the prostate or there are suspicious lymph nodes, it is called locally advanced.1 The European guideline recommends offering radical prostatectomy to selected patients, with extended removal of the lymph nodes, and also accepts radiotherapy with 2 to 3 years of hormone therapy.2 When I recommend surgery for high-risk disease, I advise operating as soon as possible, without hormone therapy while the patient waits.

What high-risk cancer means

The European guideline groups prostate cancer by risk using the biopsy ISUP grade group, the PSA and the rectal exam:1

GroupHow it is defined
Low riskISUP 1, PSA below 10 ng/mL and tumor confined to the prostate on the rectal exam
Intermediate riskISUP 2 or 3, or PSA between 10 and 20 ng/mL, with tumor confined to the prostate on the rectal exam
High riskISUP 4 or 5, or PSA above 20 ng/mL
Locally advancedTumor beyond the prostate on the rectal exam (cT3 or cT4) or suspicious lymph nodes on imaging, with any ISUP and any PSA

The pages on Gleason and ISUP and on PSA explain these numbers.

Not all high-risk cancer is the same

High risk covers very different cases. In a European study of 1,360 patients operated on at eight centers, the authors split high-risk cancer into three groups by combining three factors: tumor beyond the prostate on the rectal exam (cT3 or cT4), Gleason 8 to 10, and PSA above 20 ng/mL.3

GroupFactorsFree of cancer death at 10 years
Good prognosisA single factor95.4%
Intermediate prognosisPSA above 20 and tumor beyond the prostate88.3%
Poor prognosisGleason 8 to 10 with at least one other factor79.7%

The European guideline also notes that not every patient with high-risk cancer has a poor prognosis after prostatectomy.2

Before deciding: the scans

With high-risk cancer, the first question is whether the cancer has spread outside the prostate. The proPSMA study randomized 302 men with high-risk cancer to PSMA PET or to CT plus bone scan. Accuracy was 92% with PSMA PET and 65% with the conventional scans.4

Prostate MRI shows whether the tumor reaches the capsule, the seminal vesicles or the sphincter. With these scans, we know whether surgery is possible and how to plan it.

Surgery or radiotherapy

No study has compared surgery and radiotherapy head to head in high-risk disease. A Scandinavian randomized trial, SPCG-15, is comparing the two in locally advanced cancer.2 Until then, the European guideline recommends:2

SituationSurgeryRadiotherapy
High riskOffer to selected patients, with extended lymph node dissectionWith hormone therapy for 2 to 3 years
Locally advanced, no suspicious nodesOffer to selected patients, as part of combined treatmentWith hormone therapy for at least 2 years

For high-risk disease, the guideline does not recommend HIFU, cryotherapy or other focal treatments.2 The surgery or radiotherapy page compares the side effects of each on urine, erections and the bowel.

How surgery is done for high-risk cancer

Robotic radical prostatectomy for high-risk cancer follows a few rules:

  • Who can have surgery: surgery is indicated when the tumor is not fixed to the pelvic wall and has not invaded the urethral sphincter.2
  • Lymph nodes: when the lymph nodes are removed, the guideline recommends an extended dissection.2 In my practice, it is always extended. The page on lymph node dissection explains how it is done.
  • A suspicious node during surgery: the guideline advises going ahead with the prostatectomy, because it may improve survival. Frozen section of the nodes during surgery is not recommended.2
  • Erection nerves: the guideline advises preserving them when the risk that the tumor has spread outside the prostate on that side is low.2 I preserve the nerves whenever possible, side by side.
  • No hormone therapy beforehand: hormone therapy before prostatectomy is not indicated.2

After surgery

Before surgery, a patient with high-risk cancer should know that the operation may be part of combined treatment, with radiotherapy or hormone therapy afterwards. Even so, almost half of patients remain free of recurrence at five years without further treatment.2

Two studies published in 2020 compared radiotherapy right after surgery with salvage radiotherapy, given only if the PSA rises:

  • RADICALS-RT: 1,396 patients. At five years, 85% had no PSA rise with immediate radiotherapy and 88% with salvage. Immediate radiotherapy caused more urine leakage and more urethral narrowing.5
  • ARTISTIC: a combined analysis of three trials with 2,153 patients found no advantage for immediate radiotherapy. At five years, 89% and 88% were free of recurrence.6

So the usual approach is to follow the PSA after prostatectomy and treat early if it rises. The European guideline still considers radiotherapy right after surgery when the pathology report shows ISUP 4 or 5 with tumor beyond the prostate (pT3) and negative lymph nodes.2 The prostatectomy pathology report contains this information.

How long to wait

According to the European guideline, treatment of high-risk cancer can be delayed for up to three months after diagnosis without harming cancer control. Delays of six to nine months were linked to more PSA recurrence and worse pathology results.2

When I recommend surgery for high-risk disease, I advise operating as soon as possible. The prostatectomy page explains how long you can wait.

How I approach it

At the consultation, I review the biopsy, PSA, MRI and PSMA PET and explain which risk group your case falls into. We talk about surgery and radiotherapy, what each offers and what may come afterwards.

I have a PhD from the University of São Paulo Medical School and have performed more than 1,500 robotic and laparoscopic operations, more than 500 of them robotic. When I operate on high-risk cancer, the lymph node dissection is extended, and I preserve the nerves whenever possible.

If you already have a diagnosis and want another assessment, a second opinion can be done entirely online, in English, with your test results sent in advance.

Send your case

If you have received a diagnosis and would like my opinion on your case before a consultation, fill in the form below. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.

Frequently asked questions

What is high-risk prostate cancer?

In the European guideline, it is cancer with ISUP grade group 4 or 5 on biopsy or a PSA above 20 ng/mL. When the rectal exam shows the tumor has grown beyond the prostate (cT3 or cT4), or when there are suspicious lymph nodes, the disease is called locally advanced.1

Can high-risk prostate cancer be treated with surgery?

Yes. The European guideline recommends offering radical prostatectomy to selected patients with high-risk cancer, and to selected patients with locally advanced disease without suspicious lymph nodes, as part of combined treatment.2 Surgery is indicated when the tumor is not fixed to the pelvic wall and has not invaded the urethral sphincter.2

For high-risk prostate cancer, is surgery or radiotherapy better?

No study has compared the two head to head in high-risk disease. The European guideline accepts both. Radiotherapy is combined with 2 to 3 years of hormone therapy, and surgery includes extended removal of the lymph nodes.2 The choice depends on the tumor, your age, your health and what you want to preserve.

Do I need hormone therapy before surgery?

No. According to the European guideline, hormone therapy before prostatectomy is not indicated.2 In my practice, I do not use hormone therapy while the patient waits for surgery.

Will I need radiotherapy after surgery?

Not always. Almost half of patients with high-risk cancer who have surgery remain free of recurrence at five years without further treatment.2 When PSA starts to rise, early salvage radiotherapy has had the same results as radiotherapy given right after surgery, with fewer urinary side effects.5,6

How long can I wait to have surgery for high-risk prostate cancer?

According to the European guideline, treatment can be delayed for up to three months after diagnosis without harming cancer control.2 In my practice, when I recommend surgery for high-risk disease, I advise operating as soon as possible.

Who operates on high-risk prostate cancer in São Paulo?

I do. I am a urologist and robotic surgeon in São Paulo, Brazil, with a PhD from the University of São Paulo Medical School and more than 500 robotic operations. When I remove the lymph nodes, the dissection is always extended. The first consultation can be online, in English.

References

  1. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: classification and staging systems. European Association of Urology; 2026. EAU
  2. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: treatment. European Association of Urology; 2026. EAU
  3. Joniau S, Briganti A, Gontero P, et al. Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study. Eur Urol. 2015;67(1):157-164. PubMed
  4. Hofman MS, Lawrentschuk N, Francis RJ, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395(10231):1208-1216. PubMed
  5. Parker CC, Clarke NW, Cook AD, et al. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial. Lancet. 2020;396(10260):1413-1421. PubMed
  6. Vale CL, Fisher D, Kneebone A, et al. Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data. Lancet. 2020;396(10260):1422-1431. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation5.0186 Google reviews

Related guides